| Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade VK Arora, E Schenkein, R Murali, SK Subudhi, J Wongvipat, MD Balbas, ... Cell 155 (6), 1309-1322, 2013 | 990 | 2013 |
| Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma F Azimi, RA Scolyer, P Rumcheva, M Moncrieff, R Murali, SW McCarthy, ... Journal of Clinical Oncology 30 (21), 2678-2683, 2012 | 867 | 2012 |
| Germline mutations in BAP1 predispose to melanocytic tumors T Wiesner, AC Obenauf, R Murali, I Fried, KG Griewank, P Ulz, ... Nature genetics 43 (10), 1018-1021, 2011 | 769 | 2011 |
| Classification of endometrial carcinoma: more than two types R Murali, RA Soslow, B Weigelt The Lancet Oncology 15 (7), e268-e278, 2014 | 683 | 2014 |
| HER kinase inhibition in patients with HER2-and HER3-mutant cancers DM Hyman, SA Piha-Paul, H Won, J Rodon, C Saura, GI Shapiro, D Juric, ... Nature 554 (7691), 189-194, 2018 | 671 | 2018 |
| Kinase fusions are frequent in Spitz tumours and spitzoid melanomas T Wiesner, J He, R Yelensky, R Esteve-Puig, T Botton, I Yeh, D Lipson, ... Nature communications 5, 3116, 2014 | 592 | 2014 |
| Copy number alteration burden predicts prostate cancer relapse H Hieronymus, N Schultz, A Gopalan, BS Carver, MT Chang, Y Xiao, ... Proceedings of the National Academy of Sciences 111 (30), 11139-11144, 2014 | 370 | 2014 |
| A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia S Shah, KA Schrader, E Waanders, AE Timms, J Vijai, C Miething, ... Nature genetics 45 (10), 1226-1231, 2013 | 339 | 2013 |
| A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. T Wiesner, R Murali, I Fried, L Cerroni, K Busam, H Kutzner, BC Bastian The American journal of surgical pathology 36 (6), 818-830, 2012 | 302 | 2012 |
| Tumours associated with BAP1 mutations R Murali, T Wiesner, RA Scolyer Pathology 45 (2), 116-126, 2013 | 300 | 2013 |
| TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma KG Griewank, R Murali, JA Puig-Butille, B Schilling, E Livingstone, ... Journal of the National Cancer Institute 106 (9), dju246, 2014 | 269 | 2014 |
| BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site J Bauer, P Büttner, R Murali, I Okamoto, NA Kolaitis, MT Landi, ... Pigment cell & melanoma research 24 (2), 345-351, 2011 | 261 | 2011 |
| Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death H Hieronymus, R Murali, A Tin, K Yadav, W Abida, H Moller, D Berney, ... eLife 7, e37294, 2018 | 254 | 2018 |
| Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway AH Shain, M Garrido, T Botton, E Talevich, I Yeh, JZ Sanborn, J Chung, ... Nature genetics 47 (10), 1194-1199, 2015 | 253 | 2015 |
| Diverse BRCA1 and BRCA2 reversion mutations in circulating cell-free DNA of therapy-resistant breast or ovarian cancer B Weigelt, I Comino-Méndez, I de Bruijn, L Tian, JL Meisel, ... Clinical Cancer Research 23 (21), 6708-6720, 2017 | 235 | 2017 |
| Alternative transcription initiation leads to expression of a novel ALK isoform in cancer T Wiesner, W Lee, AC Obenauf, L Ran, R Murali, QF Zhang, EWP Wong, ... Nature 526 (7573), 453-457, 2015 | 235 | 2015 |
| High-grade endometrial carcinomas: Morphologic and immunohistochemical features, diagnostic challenges and recommendations R Murali, B Davidson, O Fadare, JA Carlson, CP Crum, CB Gilks, JA Irving, ... International Journal of Gynecological Pathology 38 (1 Suppl 1), S40, 2019 | 208 | 2019 |
| High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations R Murali, B Davidson, O Fadare, JA Carlson, CP Crum, CB Gilks, JA Irving, ... International Journal of Gynecological Pathology 38 (1 Suppl 1), S40, 2019 | 208 | 2019 |
| Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas KG Griewank, H Westekemper, R Murali, M Mach, B Schilling, T Wiesner, ... Clinical Cancer Research 19 (12), 3143-3152, 2013 | 207 | 2013 |
| Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide S Walpole, AL Pritchard, CM Cebulla, R Pilarski, M Stautberg, ... JNCI: Journal of the National Cancer Institute 110 (12), 1328-1341, 2018 | 206 | 2018 |
